United States · Series D startup

Who invested in Peptimmune

3 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$69Mraised across 3 rounds since 2003, from 3 sources

$41MSeries A$19MSeries C$8.9MSeries D
Latest round
Series D, $8.9MJul 2008
Biggest round
$41MSeries A · Mar 2003
Investors
7
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

200320042005200620072008
$41MSeries A$19MSeries C$8.9MSeries D
First round
Series A, $41M
Mar 2003
Biggest round
$41M
Series A · Mar 2003
Usual gap between rounds
3.1 years
the median of 2

The rounds

  1. Jul 2008
    Series D$8.9M1 new4 returning

    From a historical funding record

  2. Jun 2005
    Series C$19M4 returning

    From a historical funding record

  3. Mar 2003

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

The exit

ExitBuyerPriceWhen
AcquiredGenzymeundisclosedJul 1999

From historical deal records. Wrong? Tell us.

Everyone who backed them

MPM CapitalPrivate equity3rounds
Hunt VenturesVC firm2rounds
Vanguard VenturesGrowth equity2rounds
SVB CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Peptimmune

Who invested in Peptimmune?

Peptimmune's investors include New Enterprise Associates, MPM Capital, Prism Venture Management, Hunt Ventures and Vanguard Ventures, and 2 more on record.

How much has Peptimmune raised?

Peptimmune has raised $69M across 3 rounds since 2003.

When did Peptimmune last raise?

Peptimmune's most recent round was a Series D of $8.9M in Jul 2008.

What was Peptimmune's biggest round?

Peptimmune's largest round on record is $41M (Series A), in Mar 2003.

Who backed Peptimmune first?

Peptimmune's first round on record, in Mar 2003, was backed by New Enterprise Associates, MPM Capital and Prism Venture Management and 3 others.

What stage is Peptimmune at?

Peptimmune's latest named round is a Series D, in Jul 2008.

Where is Peptimmune based?

Peptimmune is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.